Released on: March 3, 2008, 4:44 am

Press Release Author: The Scott Partnership

Industry: Pharmaceuticals

Press Release Summary: Manchester, UK (March 03 2008) RTS Life Science, a worldwide
supplier of automated sample management and drug delivery testing systems, today
announces that it will be launching its revolutionary Automated Blood Fractionation
(ABF) system at European Spring Biobanking and Biorepositories 2008,15-16 April,
Zurich, Switzerland. This unique patent-pending* high throughput blood fractionation
system is used to extract buffy coat (white blood cells) from whole blood samples.


Press Release Body: Manchester, UK (March 03 2008) RTS Life Science, a worldwide
supplier of automated sample management and drug delivery testing systems, today
announces that it will be launching its revolutionary Automated Blood Fractionation
(ABF) system at European Spring Biobanking and Biorepositories 2008,15-16 April,
Zurich, Switzerland. This unique patent-pending* high throughput blood fractionation
system is used to extract buffy coat (white blood cells) from whole blood samples.
The innovative, upgradable system provides a fully automated solution to blood
fractionation and processing. The ABF system is a self-contained unit capable of
processing up to 500 samples per day, providing substantial time and labour cost
savings compared with manual fractionation. In addition, this new automated system
from RTS Life Science provides the benefits of cost and labour saving, removal of
human error, increased reproducibility and facilitation of sample tracking and
auditing.
The revolutionary ABF system incorporates unique Vision System technology which
measures the height of each fraction and calculates the volume of each layer
following fractionation via centrifugation. The ABF solution also offers significant
health and safety benefits by reducing employee exposure to unscreened blood and a
LIMS (Laboratory Information Management System) interface ensures ease of
acquisition and manipulation of data.
Kristian Spreckley, Blood Fractionation Product Manager at RTS Life Science
comments, “RTS has developed this new ABF system in response to the unique needs of
the biobanking industry. The system should be installed to automate blood
fractionation and buffy coat retrieval from whole blood in any high volume
environment.”
As well as the fully Automated Blood Fractionation System, RTS also offers this
solution as a semi-automated system. To be among the first to see this innovative
new offering from RTS Life Science please visit Biobanking and Biorepositories 2008,
15-16 April, Zurich, Switzerland.
More information about RTS Life Science is available at www.rtslifescience.com or by
e-mail lifescience.info@rts-group.com.
*Patent Application Number 0422358.2
About RTS Life Science:

RTS Life Science is a UK-based supplier of drug discovery and drug delivery
automation solutions for large scale sample management and high throughput testing
in laboratories. RTS Life Science is owned by Robotic Technology Systems PLC, an
AIM-listed company.

For further press information please contact: Sophie Downend, The Scott Partnership,
1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA United Kingdom Tel: +
44 1477 539539 Fax: +44 1477 539540 e-mail to: rts@scottpr.com


Web Site: http://

Contact Details: For further press information please contact: Sophie Downend, The
Scott Partnership, 1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA
United Kingdom Tel: + 44 1477 539539 Fax: +44 1477 539540 e-mail to:
rts@scottpr.com